Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 12;22(1):531.
doi: 10.1186/s12885-022-09547-8.

Factors that contribute to disparities in time to acute leukemia diagnosis in young people: an in depth qualitative interview study

Affiliations

Factors that contribute to disparities in time to acute leukemia diagnosis in young people: an in depth qualitative interview study

Lucky Ding et al. BMC Cancer. .

Abstract

Background: Racial and ethnic disparities in outcomes for Black and Hispanic children with acute leukemia have been well documented, however little is known about the determinants of diagnostic delays in pediatric leukemia in the United States. The primary objective of this study is to identify factors contributing to delays preceding a pediatric leukemia diagnosis.

Methods: This qualitative study utilized in-depth semi-structured interviews. Parents and/or patients within two years of receiving a new acute leukemia diagnosis were asked to reflect upon their family's experiences preceding the patient's diagnosis. Subjects were purposively sampled for maximum variation in race, ethnicity, income, and language. Interviews were analyzed using inductive theory-building and the constant comparative method to understand the process of diagnosis. Chart review was conducted to complement qualitative data.

Results: Thirty-two interviews were conducted with a diverse population of English and Spanish speaking participants from two tertiary care pediatric cancer centers. Parents reported feeling frustrated when their intuition conflicted with providers' management decisions. Many felt laboratory testing was not performed soon enough. Additional contributors to delays included misattribution of vague symptoms to more common diagnoses, difficulties in obtaining appointments, and financial disincentives to seek urgent or emergent care. Reports of difficulty obtaining timely appointments and financial concerns were disproportionately raised among low-income Black and Hispanic participants. Comparatively, parents with prior healthcare experiences felt better able to navigate the system and advocate for additional testing at symptom onset.

Conclusions: While there are disease-related factors contributing to delays in diagnosis, it is important to recognize there are multiple non-disease-related factors that also contribute to delays. Evidence-based approaches to reduce outcome disparities in pediatric cancer likely need to start in the primary care setting where timeliness of diagnosis can be addressed.

Keywords: Disparities; Leukemia; Pediatric oncology; Qualitative research; Race/Ethnicity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Similar articles

Cited by

  • Perspectives of Caregivers on Access to Health Care for Children with CKD.
    Guha C, Khalid R, Mallitt KA, van Zwieten A, Francis A, Kim S, Teixeira-Pinto A, Aquino M, Bernier-Jean A, Johnson DW, Hahn D, Reidlinger D, Ryan EG, Mackie F, McCarthy H, Varghese J, Kiriwandeniya C, Howard K, Larkins N, Macauley L, Walker A, Howell M, Caldwell P, Woodleigh R, Jesudason S, Carter S, Kennedy S, Alexander S, McTaggart S, Craig JC, Hawley CM, Wong G, Jaure A; NAVKIDS2 trial steering committee; NAVKIDS trial steering committee. Guha C, et al. Kidney Int Rep. 2024 Sep 2;9(11):3177-3189. doi: 10.1016/j.ekir.2024.08.029. eCollection 2024 Nov. Kidney Int Rep. 2024. PMID: 39534191 Free PMC article.

References

    1. American Cancer Society: Survival Rates for Childhood Leukemias. Atlanta: American Cancer Society. [updated 2019 Feb 12; cited 2020 May 26]. Available from: www.cancer.org/cancer/leukemia-in-children/detection-diagnosis-staging/s...
    1. Aplenc R, Alonzo TA, Gerbing RB, Smith FO, Meshinchi S, Ross JA, et al. Ethnicity and survival in children acute myeloid leukemia: a report from the children’s oncology group. Blood. 2006;108:74–80. doi: 10.1182/blood-2005-10-4004. - DOI - PMC - PubMed
    1. Gamis AS, Alonzo TA, Meshinchi S, Sung L, Gerbing RB, Raimondi SC, et al. Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III children's oncology group trial AAML05310. J Clin Oncol. 2014;32:3021–3032. doi: 10.1200/JCO.2014.55.3628. - DOI - PMC - PubMed
    1. Alcalai R, Ben-Yehuda D, Ronen I, Paltiel O. Ethnicity and prognosis in acute myeloid leukemia. Am J Hematol. 2003;72:127–134. doi: 10.1002/ajh.10270. - DOI - PubMed
    1. Acharya S, Hsieh S, Shinohara ET, DeWees T, Frangoul H, Perkins SM. Effects of race/ethnicity and socioeconomic status on outcome in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2016;38:350–354. doi: 10.1097/MPH.0000000000000591. - DOI - PubMed